Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16059 | 608 | 37.5 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DERMCIDIN ISOFORM 2 | Author keyword | 3 | 100% | 0% | 3 |
2 | ACUTE ISCHEMIC HEART DISEASE | Author keyword | 3 | 45% | 1% | 5 |
3 | GEA 3175 | Author keyword | 2 | 44% | 1% | 4 |
4 | CE WIB801C | Author keyword | 2 | 67% | 0% | 2 |
5 | FARMACOL PSICOBIOL | Address | 2 | 16% | 2% | 10 |
6 | NITRIC OXIDE RESISTANCE | Author keyword | 1 | 38% | 0% | 3 |
7 | PLATELET BIOL GRP | Address | 1 | 38% | 0% | 3 |
8 | CLIN BIOL SCIDIABET UNIT | Address | 1 | 100% | 0% | 2 |
9 | P388D1 CELL LINE | Author keyword | 1 | 50% | 0% | 2 |
10 | HIGHLAND CLIN IL | Address | 1 | 33% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DERMCIDIN ISOFORM 2 | 3 | 100% | 0% | 3 | Search DERMCIDIN+ISOFORM+2 | Search DERMCIDIN+ISOFORM+2 |
2 | ACUTE ISCHEMIC HEART DISEASE | 3 | 45% | 1% | 5 | Search ACUTE+ISCHEMIC+HEART+DISEASE | Search ACUTE+ISCHEMIC+HEART+DISEASE |
3 | GEA 3175 | 2 | 44% | 1% | 4 | Search GEA+3175 | Search GEA+3175 |
4 | CE WIB801C | 2 | 67% | 0% | 2 | Search CE+WIB801C | Search CE+WIB801C |
5 | NITRIC OXIDE RESISTANCE | 1 | 38% | 0% | 3 | Search NITRIC+OXIDE+RESISTANCE | Search NITRIC+OXIDE+RESISTANCE |
6 | P388D1 CELL LINE | 1 | 50% | 0% | 2 | Search P388D1+CELL+LINE | Search P388D1+CELL+LINE |
7 | THROMBOTIC DISEASES | 1 | 33% | 0% | 2 | Search THROMBOTIC+DISEASES | Search THROMBOTIC+DISEASES |
8 | PROSTAGLANDIN E2 RECEPTOR | 1 | 23% | 0% | 3 | Search PROSTAGLANDIN+E2+RECEPTOR | Search PROSTAGLANDIN+E2+RECEPTOR |
9 | VASODILATOR STIMULATED PHOSPHOPROTEIN VASP | 1 | 21% | 0% | 3 | Search VASODILATOR+STIMULATED+PHOSPHOPROTEIN+VASP | Search VASODILATOR+STIMULATED+PHOSPHOPROTEIN+VASP |
10 | A2 INHIBITORS | 1 | 50% | 0% | 1 | Search A2+INHIBITORS | Search A2+INHIBITORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROSTAGLANDIN E1 I2 RECEPTOR ACTIVITY | 8 | 100% | 1% | 5 |
2 | GUANOSINE 3 5 CYCLIC MONOPHOSPHATE | 4 | 33% | 2% | 11 |
3 | CYTOSOLIC IONIZED CA2 | 4 | 75% | 0% | 3 |
4 | CGMP INDEPENDENT MECHANISMS | 2 | 38% | 1% | 5 |
5 | GUANOSINE 3 5 MONOPHOSPHATE | 2 | 13% | 3% | 17 |
6 | INTACT HUMAN PLATELETS | 2 | 10% | 3% | 19 |
7 | SIN 1 | 2 | 22% | 1% | 8 |
8 | EDRF ACTIVITY | 1 | 50% | 0% | 2 |
9 | PLATELET STIMULATED THROMBIN | 1 | 100% | 0% | 2 |
10 | SYSTEM YL | 1 | 19% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nitric oxide insufficiency, platelet activation, and arterial thrombosis | 2001 | 278 | 72 | 29% |
Platelet-derived nitric oxide signaling and regulation | 2007 | 49 | 116 | 35% |
Unresolved roles of platelet nitric oxide synthase | 2008 | 27 | 94 | 56% |
Platelet abnormalities in diabetes mellitus | 2010 | 45 | 84 | 17% |
Nitric oxide and superoxide detection in human platelets | 1999 | 19 | 14 | 86% |
Platelet dysfunction in central obesity | 2009 | 51 | 131 | 18% |
Factors Contributing to Increased Platelet Reactivity in People With Diabetes | 2009 | 24 | 21 | 29% |
Insulin, Insulin Resistance, and Platelet Signaling in Diabetes | 2009 | 16 | 31 | 29% |
Nitric oxide and its relationship to thrombotic disorders | 2003 | 32 | 55 | 36% |
Nitric oxide and platelet aggregation | 1999 | 70 | 97 | 21% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FARMACOL PSICOBIOL | 2 | 16% | 1.6% | 10 |
2 | PLATELET BIOL GRP | 1 | 38% | 0.5% | 3 |
3 | CLIN BIOL SCIDIABET UNIT | 1 | 100% | 0.3% | 2 |
4 | HIGHLAND CLIN IL | 1 | 33% | 0.5% | 3 |
5 | SURG GASTROENTEROL PROCTOL | 1 | 33% | 0.3% | 2 |
6 | DISCIPLINA FARMACOL | 1 | 17% | 0.7% | 4 |
7 | CELL MOL THER EUT | 1 | 21% | 0.5% | 3 |
8 | BIOSCI BIOTECHNOL TEAM | 1 | 50% | 0.2% | 1 |
9 | CARDIOL UNITBASIL HETZEL | 1 | 50% | 0.2% | 1 |
10 | HOSP CLIN PROV IDIB S | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000261701 | PRIMA CLIN MED//BIOMED EVOLUT AGING//CLIN LIPID |
2 | 0.0000149055 | MOLSIDOMINE//CLIN INTERNAL DIS 3//LINSIDOMINE |
3 | 0.0000138151 | EDRF//NG NITRO L ARGININE//EDRF ENDOTHELIUM DERIVED RELAXING FACTOR |
4 | 0.0000132996 | YC 1//BAY 41 2272//SOLUBLE GUANYLYL CYCLASE |
5 | 0.0000122049 | POLYASPARTOYL L ARGININE//BEIJING S HYDRONE PEPTIDES//CHAIR SEMEIOL MED METHODOL |
6 | 0.0000117263 | HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2 |
7 | 0.0000111840 | DIABETOL DDG//JOHN COOK RENAL UNIT//PLATELET HYPERSENSITIVITY |
8 | 0.0000109711 | TYPE II CGMP DEPENDENT PROTEIN KINASE//CGMP DEPENDENT PROTEIN KINASE//CANC MOL BIOL SECT |
9 | 0.0000101711 | VESSEL WALL INJURY//INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI//CLIN BIOCHEM IMMUNOHEMATOL |
10 | 0.0000098924 | CORONARY ARTERIAL TONE//VASC BIOL MED ERFURT//PLATELET NEUTROPHIL INTERACTION |